Department of Health presents informational updates on EOB delivery, network adequacy, drug-price reporting and HMO rules

The Minnesota Department of Health provided an informational presentation to the House Commerce Committee on several policy provisions; no committee vote was taken.

Lisa Timmian, director of government relations for the Minnesota Department of Health, and other agency representatives outlined four primary updates. First, a proposal to allow explanation-of-benefit (EOB) notices to be delivered electronically when consumers opt in, reducing reliance on postal mail. Second, an update to Minnesota's network adequacy rules to align with federal standards for the state-based health exchange, adopting county classifications (for example, large metro and rural) and requiring plans to justify unmet standards using data; the committee was told the state must conform by Jan. 1, 2026.

Third, the department described technical updates and clarifications to the Prescription Drug Price Transparency Act, including references to Section 340B programs and refinements intended to improve reporting clarity and compliance. The panel described these as technical fixes to strengthen data collection and oversight. Finally, the department presented modernization of HMO regulation to align state rules with national standards and the National Association of Insurance Commissioners' holding-company and risk-management frameworks, including improved data collection and solvency assessments.

Department staff remained available to answer member questions; no public testimony was recorded. Committee members were told the measure will be heard in the House Health Committee the following day.